Synthesis of (−)-Cannabimovone and Structural Reassignment of Anhydrocannabimovone through Gold(I)-Catalyzed Cycloisomerization

Angewandte Chemie - International Edition

Volumn 55, Issue 25, 2016, Pages 7121-7125

  Carreras, Javier ^a   Kirillova, Mariia S ^a   Echavarren, Antonio M ^a,b  

^a BARCELONA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Spain)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

cannabinoids; cycloisomerization; gold; oxy Michael reaction; total synthesis

Indexed keywords

ADDITION REACTIONS; CATALYSIS; GOLD; HEMP; ISOMERIZATION; SYNTHESIS (CHEMICAL);

CANNABINOIDS; CANNABIS SATIVA; CYCLOISOMERIZATIONS; OXY-MICHAEL REACTION; STEREO-SELECTIVE; TOTAL SYNTHESIS;

GOLD COMPOUNDS;

EID: 84992299218     PISSN: 14337851     EISSN: 15213773     Source Type: Journal    
DOI: 10.1002/anie.201601834     Document Type: Article

References (70)

1. G. A. Thakur, R. I. Duclos Jr, A. Makriyannis, Life Sci. 2005, 78, 454–466;
2. Marijuana and the Cannabinoids (Ed. M. A. ElSohly), Humana, Totowa, NJ, 2007;
3. P. J. Robson, Drug Test. Anal. 2014, 6, 24–30;
4. R. Mechoulam, L. O. Hanus, R. Pertwee, A. C. Howlett, Nat. Rev. Neurosci. 2014, 15, 757–764;
5. Special issue, Nature 2015, 525, S1–S18.
6. O. Aizpurua-Olaizola, U. Soydaner, E. Öztürk, D. Schibano, Y. Simsir, P. Navarro, N. Etxebarria, A. Usobiaga, J. Nat. Prod. 2016, 79, 324–331.
7. For example:
8. R. A. Archer, W. B. Blanchard, W. A. Day, D. W. Johnson, E. R. Lavagnino, C. W. Ryan, J. E. Baldwin, J. Org. Chem. 1977, 42, 2277–2284;
9. R. Mechoulam, N. Lander, A. University, J. Zahalka, Tetrahedron: Asymmetry 1990, 1, 315–318;
10. S. H. Burstein, C. A. Audette, A. Breuer, W. A. Devane, S. Colodner, S. A. Doyle, R. Mechoulam, J. Med. Chem. 1992, 35, 3135–3141.
11. D. D. Dixon, D. Sethumadhavan, T. Benneche, A. R. Banaag, M. A. Tius, G. A. Thakur, A. Bowman, J. T. Wood, A. Makriyannis, J. Med. Chem. 2010, 53, 5656–5666;
12. F. Gläser, M. C. Bröhmer, T. Hurrle, M. Nieger, S. Bräse, Eur. J. Org. Chem. 2015, 1516–1524.
13. J. Zajicek, P. Fox, H. Sanders, D. Wright, J. Vickery, A. Nunn, A. Thompson, Lancet 2003, 362, 1517–1526;
14. K. R. Müller-Vahl, H. Prevedel, K. Theloe, H. Kolbe, H. M. Emrich, U. Schneider, Neuropsychopharmacology 2003, 28, 384–388;
15. K. Mackie, Annu. Rev. Pharmacol. Toxicol. 2006, 46, 101–122;
16. A. T. El-Alfy, K. Ivey, K. Robinson, S. Ahmed, M. Radwan, D. Slade, I. Khan, M. ElSohly, S. Ross, Pharmacol. Biochem. Behav. 2010, 95, 434–442;
17. M. E. Lynch, F. Campbell, Br. J. Clin. Pharmacol. 2011, 72, 735–744.
18. D. A. Evans, E. A. Shaughnessy, D. M. Barnes, Tetrahedron Lett. 1997, 38, 3193–3194;
19. B. M. Trost, K. Dogra, Org. Lett. 2007, 9, 861–863;
20. L.-J. Cheng, J.-H. Xie, Y. Chen, L.-X. Wang, Q.-L. Zhou, Org. Lett. 2013, 15, 764–767;
21. M. A. Schafroth, G. Zuccarello, S. Krautwald, D. Sarlah, E. M. Carreira, Angew. Chem. Int. Ed. 2014, 53, 13898–13901;
22. Angew. Chem. 2014, 126, 14118–14121;
23. F. Klotter, A. Studer, Angew. Chem. Int. Ed. 2015, 54, 8547–8550;
24. Angew. Chem. 2015, 127, 8667–8670.
25. R. Mechoulam, L. A. Parker, R. Gallily, J. Clin. Pharmacol. 2002, 42, 11S–19S;
26. C. Scuderi, D. D. Filippis, T. Iuvone, A. Blasio, A. Steardo, G. Esposito, Phytother. Res. 2009, 23, 597–602;
27. E. Blessing, M. Steenkamp, J. Manzanares, C. Marmar, Neurotherapeutics 2015, 12, 825–836.
28. I. G. Karniol, I. Shirakawa, N. Kasinski, A. Pfeferman, E. A. Carlini, Eur. J. Pharmacol. 1974, 28, 172–177;
29. C. J. A. Morgan, G. Schafer, T. P. Freeman, H. V. Curran, Br. J. Psychiatry 2010, 197, 285–290;
30. J. Sastre-Garriga, C. Vila, S. Clissold, X. Montalban, Expert Rev. Neurother. 2011, 11, 627–637.
31. O. Taglialatela-Scafati, A. Pagani, F. Scala, L. De Petrocellis, V. Di Marzo, G. Grassi, G. Appendino, Eur. J. Org. Chem. 2010, 2067–2072.
32. C. Nieto-Oberhuber, M. P. Muñoz, S. López, E. Jiménez-Núñez, C. Nevado, E. Herrero-Gómez, M. Raducan, A. M. Echavarren, Chem. Eur. J. 2006, 12, 1677–1693;
33. V. López-Carrillo, N. Huguet, Á. Mosquera, A. M. Echavarren, Chem. Eur. J. 2011, 17, 10972–10978.
34. R. Dorel, A. M. Echavarren, Chem. Rev. 2015, 115, 9028–9072.
35. Synthesis of indenes by cycloisomerization of 1,5-enynes: A. Martínez, P. García-García, M. A. Fernández-Rodríguez, F. Rodríguez, R. Sanz, Angew. Chem. Int. Ed. 2010, 49, 4633–4637;
36. Angew. Chem. 2010, 122, 4737–4741.
37. Total synthesis through gold- or platinum catalyzed cycloisomerization of 1,5-enynes:
38. V. Mamane, T. Gress, H. Krause, A. Fürstner, J. Am. Chem. Soc. 2004, 126, 8654–8655;
39. Y. Harrak, C. Blaszykowski, M. Bernard, K. Cariou, E. Mainetti, V. Mouriès, A.-L. Dhimane, L. Fensterbank, M. Malacria, J. Am. Chem. Soc. 2004, 126, 8656–8657;
40. A. Fürstner, P. Hannen, Chem. Eur. J. 2006, 12, 3006–3019;
41. A. Fürstner, A. Schlecker, Chem. Eur. J. 2008, 14, 9181–9191;
42. G. Lemière, V. Gandon, K. Cariou, A. Hours, T. Fukuyama, A.-L. Dhimane, L. Fensterbank, M. Malacria, J. Am. Chem. Soc. 2009, 131, 2993–3006.
43. Total synthesis through gold-catalyzed Conia-type cyclizations of 1,5-enynes:
44. S. T. Staben, J. J. Kennedy-Smith, D. Huang, B. K. Corkey, R. L. LaLonde, F. D. Toste, Angew. Chem. Int. Ed. 2006, 45, 5991–5994;
45. Angew. Chem. 2006, 118, 6137–6140;
46. X. Linghu, J. J. Kennedy-Smith, F. D. Toste, Angew. Chem. Int. Ed. 2007, 46, 7671–7673;
47. Angew. Chem. 2007, 119, 7815–7817;
48. G. Bellavance, L. Barriault, Angew. Chem. Int. Ed. 2014, 53, 6701–6704;
49. Angew. Chem. 2014, 126, 6819–6822.
50. Reviews on the application of gold catalysis to the synthesis of natural products:
51. A. Fürstner, Chem. Soc. Rev. 2009, 38, 3208–3221;
52. M. Rudolph, A. S. K.; Hashmi, Chem. Soc. Rev. 2012, 41, 2448–2462;
53. Hashmi, Chem. Soc. Rev. 2012, 41, 2448–2462;
54. A. Fürstner, Acc. Chem. Res. 2014, 47, 925–938;
55. Y. Zhang, T.; Luo, Z. Yang, Nat. Prod. Rep. 2014, 31, 489–503;
56. Luo, Z. Yang, Nat. Prod. Rep. 2014, 31, 489–503;
57. D. Pflästerer, A. S. K. Hashmi, Chem. Soc. Rev. 2016, 45, 1331–1367.
58. Procedure according to: G. Koza, C. Theunissen, J. R. Al Dulayymi, M. S. Baird, Tetrahedron 2009, 65, 10214–10229;
59. Spectral data and optical rotation in accordance with those previously reported for (R,R)-10: A. Kramer, H. Pfander, Helv. Chim. Acta 1982, 65, 293–301.
60. For example:
61. S. Kim, I. S. Kee, Y. H. Park, J. H. Park, Synlett 1991, 183–184;
62. W. H. Kim, A. R. Angeles, J. H. Lee, S. J. Danishefsky, Tetrahedron Lett. 2009, 50, 6440–6441.
63. [9].
64. CCDC 1454956 (6), CCDC 1454957 (21) and CCDC 1454958 (23) contain the supplementary crystallographic data. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre.
65. See the Supporting Information for more details.
66. Similarly, the cis addition was also favored for the pyrrolidine-promoted process. See the Supporting Information for more details.
67. M. W. Lodewyk, M. R. Siebert, D. J. Tantillo, Chem. Rev. 2012, 112, 1839–1862; some recent examples:
68. K. N. White, T. Amagata, A. G. Oliver, K. Tenney, P. J. Wenzel, P. Crews, J. Org. Chem. 2008, 73, 8719–8722;
69. G. Hu, K. Liu, L. J. Williams, Org. Lett. 2008, 10, 5493–5496;
70. Y. Li, RSC Adv. 2015, 5, 36858–36864.